home Latest News Gerber Kawasaki Wealth & Investment Management Sells 45,621 Shares of iShares Nasdaq Biotechnology ETF (IBB) – Tech Know Bits

Gerber Kawasaki Wealth & Investment Management Sells 45,621 Shares of iShares Nasdaq Biotechnology ETF (IBB) – Tech Know Bits

This post was originally published on this site

Gerber Kawasaki Wealth & Investment Management trimmed its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 40.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,359 shares of the financial services provider’s stock after selling 45,621 shares during the quarter. iShares Nasdaq Biotechnology ETF comprises about 2.2% of Gerber Kawasaki Wealth & Investment Management’s portfolio, making the stock its 14th biggest position. Gerber Kawasaki Wealth & Investment Management owned approximately 0.09% of iShares Nasdaq Biotechnology ETF worth $7,418,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Ellis Investment Partners LLC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 10,590.0% in the 1st quarter. Ellis Investment Partners LLC now owns 1,761,815 shares of the financial services provider’s stock valued at $1,761,000 after purchasing an additional 1,745,334 shares during the period. Deutsche Bank AG increased its position in iShares Nasdaq Biotechnology ETF by 32,925.6% in the 4th quarter. Deutsche Bank AG now owns 1,683,314 shares of the financial services provider’s stock valued at $162,320,000 after buying an additional 1,678,217 shares in the last quarter. State of Tennessee Treasury Department bought a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter valued at about $40,732,000. Lockheed Martin Investment Management Co. increased its position in iShares Nasdaq Biotechnology ETF by 173.9% in the 4th quarter. Lockheed Martin Investment Management Co. now owns 417,400 shares of the financial services provider’s stock valued at $40,250,000 after buying an additional 265,000 shares in the last quarter. Finally, Main Management LLC increased its position in iShares Nasdaq Biotechnology ETF by 14.2% in the 4th quarter. Main Management LLC now owns 398,987 shares of the financial services provider’s stock valued at $38,474,000 after buying an additional 49,514 shares in the last quarter. 67.92% of the stock is currently owned by institutional investors.

iShares Nasdaq Biotechnology ETF stock traded up $1.50 during midday trading on Thursday, reaching $104.87. The stock had a trading volume of 69,957 shares, compared to its average volume of 2,505,390. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Tech Know Bits and is the property of of Tech Know Bits. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://techknowbits.com/2019/05/16/gerber-kawasaki-wealth-investment-management-sells-45621-shares-of-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: What is insider trading?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com’s FREE daily email newsletter.